| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT06185673 | A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia | RECRUITING | PHASE1, PHASE2 | 2023-11-28 | 2040-11 | 2030-11 |
| NCT03433027 | A Study of BB-401 in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | COMPLETED | PHASE2 | 2018-03-15 | 2020-04-06 | 2018-12-12 |